Nova Biomedical ANZCritical Care, POC, Lab, Vet, Biotech Diagnostics

Nova Biomedical is a global leader in healthcare diagnostics and bioprocessing technologies that support drug development, food and beverage analytical testing, and solutions for veterinary medicine. We are committed to advancing patient care and accelerating scientific discovery through the development of cutting-edge instrumentation and innovation. As the largest privately held in vitro diagnostics company in the United States and one of the fastest-growing worldwide, Nova serves customers in more than 100 countries. Our significant annual reinvestment in R&D fuels a robust pipeline of breakthrough technologies. Guided by our core values of customer-centricity, ingenuity, collaboration, integrity and ownership & accountability, we foster a culture that inspires employee loyalty and earns enduring trust from our customers. Our Expertise Clinical Diagnostics and Healthcare Solutions: With solutions supporting hospital critical care, diagnostics, point-of-care and lab testing to ensure we are delivering fast, accurate results for better clinical decisions. Bioprocessing and Cell Line Development Solutions: Innovative instrumentation for real-time cell culture monitoring, cell line development workflows, liquid handling quality assurance, osmolality testing and end-to-end process optimisation in biomanufacturing. Veterinary Diagnostics: High-performance analysers tailored for animal health applications. Food and Beverage Testing: Expertise supporting quality and safety in food and beverage manufacturing environments. To learn more or request a quote, contact us at: [email protected], +61 2 9417 0193 Unit 5, 372 Eastern Valley Way Chatswood NSW 2067 Australia Visit: https://www.novabiomedical.com/